about
Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trialMulticentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesCC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.Limited Accuracy of Colour Doppler Ultrasound Dynamic Tissue Perfusion Measurement in Diabetic Adults.Reconstructive kidney surgery for organ-preserving therapy of renal tumors.Serum levels of the adipokine progranulin depend on renal functionAcute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentreThe role of EUTox in uremic toxin research.Conservative treatment of the uremic syndrome.Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis.Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy.An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.Serum levels of the myokine irisin in relation to metabolic and renal function.Amplification of Mycobacterium tuberculosis from peripheral blood.Role of genetic variants of the renin-angiotensin system in chronic renal allograft injury.Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal.On-site production of a dialysis bath from dry salts. Results of solute concentration control by routine clinical chemistry.Staphylococcus colonization, mortality and morbidity in hemodialysis patients: 10 years of observation.Biased reasoning.Matrix analysis for the dissection of interactions of G-protein beta3 subunit C825T genotype, allograft function, and posttransplant hypertension in kidney transplantation.Immunoadsorption with tryptophan adsorbers for successful treatment of late steroid-refractory recurrent focal glomerulosclerosis.Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.Effects of parathyroidectomy on renal allograft survival.The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension.Renal IL-17 expression in human ANCA-associated glomerulonephritis.Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.[Acute renal failure: pathophysiology and clinical management].Baroreflex activation therapy in patients with end-stage renal failure: proof of concept.Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.Computational analysis of blood volume curves and risk of intradialytic morbid events in hemodialysis.[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men.CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.G-protein beta(3)-subunit C825T genotype and nephropathy in diabetes mellitus.G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men.Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST).
P50
Q28535223-196A7FA2-CE03-4F8A-ACA3-C81A2D14B134Q33985444-B4F134B7-5412-4F5A-823A-98C190BF1658Q34281203-94FA534E-596D-4B74-B388-E86E1CACDB45Q35903097-1B113A80-6284-4A80-8695-16D2EF07CEE3Q36003085-04940BD4-37C1-41F1-A3F3-134414162DCBQ36235757-29DF1C28-1510-4D4D-85A9-C525A39704B1Q36285602-8E66245F-EDE9-4B2E-BB66-C8DE5A8AC53CQ36560384-6340B1FB-D463-4847-8D9E-93EEDF5A4A98Q36638767-C15EC0C6-4F2C-4A4E-81E9-6F9EC64BBFDFQ36670632-92301053-C3F2-4533-9345-298D6D30DCB6Q37587267-7D670BE6-562B-4802-B46B-65C690D2751FQ37587339-19D0F3E5-1B8A-4429-9517-84E69AE59A6AQ37612189-FF74A67F-930A-4D94-839C-D031542FE054Q38925240-A663F641-E1B5-40CD-8212-6F26A530817CQ39033294-C2D9DE14-8736-4FAC-A0F0-FC0D6E96756BQ39277816-50890DEF-8DBD-48F0-999D-7D651EE650C4Q40009570-51141B94-AC8F-4BB0-A8A1-0DDB811CE429Q40857381-EA8DD152-1049-46F6-BD03-EFD01560219FQ41665134-F1302875-DD27-4101-8F6B-DA4272BE341DQ42243590-5B63051D-7E77-4C79-9C48-772125EE1906Q42269967-11033330-4916-438D-84FB-EA2D51DDFC70Q43177872-F7DEA325-77AE-4203-8D25-7D4EFE2FE169Q44235011-09C2426D-1DD2-453F-BF5D-32E588E57E41Q44606348-03CAEA16-7C8F-42B1-8822-A3082E61E3A7Q44734599-5A33623B-CC85-4ABB-BCC8-EA9BAC63D09CQ44981208-7041BB3B-A56D-4371-A07E-B5557AEFB232Q45083446-4CDB60D9-D1D6-40B4-B14A-F2A7895C6483Q45193206-BBEB7597-C419-46FF-A176-4017956BA075Q45440004-36E377C2-BE95-468D-8146-81A30DA7E0C9Q46323523-4023CECC-6148-470F-8059-BC1F7C6AEAABQ46886057-6B6D3EC3-8160-4050-8042-E9D72707299CQ48748432-18E2280C-4E39-4422-B98F-2736659D9EF3Q50699150-517A43B2-3332-477D-909D-52D80801C4FFQ52073359-DC00185E-00E4-4F28-BE1A-5E13CEB6ECDBQ52822562-C6C40708-E0E1-46AB-8EFA-2B79588F65FCQ52901493-3C4B5077-FB70-463B-BB56-9D873391BAD3Q52921101-84186817-BF2A-49BF-838C-21752D0C4941Q52969806-AB58E7BA-935F-4092-BEF7-52E233CF5041Q52970533-91B69984-8F9F-4FBD-BC93-59505290E4C9Q52975216-CFCE8EDD-64F4-491D-97D2-B0D363AECEB0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joachim Beige
@ast
Joachim Beige
@en
Joachim Beige
@es
Joachim Beige
@nl
Joachim Beige
@pt
Joachim Beige
@sl
type
label
Joachim Beige
@ast
Joachim Beige
@en
Joachim Beige
@es
Joachim Beige
@nl
Joachim Beige
@pt
Joachim Beige
@sl
prefLabel
Joachim Beige
@ast
Joachim Beige
@en
Joachim Beige
@es
Joachim Beige
@nl
Joachim Beige
@pt
Joachim Beige
@sl
P1053
A-3446-2017
P106
P1153
6701448507
P21
P31
P3829
P496
0000-0002-1907-825X